日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

First-in-human phase 1 study of RO7119929, an oral TLR7 agonist prodrug, in patients with advanced primary or metastatic liver cancers

RO7119929(一种口服TLR7激动剂前药)在晚期原发性或转移性肝癌患者中的首次人体I期研究

Yoo, Changhoon; Fabregat-Franco, Carles; Lin, Chia-Chi; Qvortrup, Camilla; Oh, Do-Youn; Yau, Thomas; Kim, Hyung-Don; Castet, Florian; Ponz Sarvise, Mariano; Hsu, Chiun; Rohrberg, Kristoffer Staal; Lichtenegger, Felix Sebastian; Franjkovic, Izolda; Kratochwil, Nicole A; Bessa, Juliana; Rossmann, Eva; Schwalie, Petra C; Rieder, Natascha; Pöschinger, Thomas; Sie, Christina Godfried; Dettling, Steffen; Schlenker, Ramona; Jiang, Tianyi; Dai, Congqi; Yun, Hongying; Hall, Elia; Yeo Te-Ying, Audrey; Hoves, Sabine; Cannarile, Michael A; Schiff, Christina; Sangro, Bruno

Immune modulation in solid tumors: a phase 1b study of RO6870810 (BET inhibitor) and atezolizumab (PD-L1 inhibitor)

实体瘤免疫调节:RO6870810(BET抑制剂)和atezolizumab(PD-L1抑制剂)的1b期研究

Marbach, Daniel; Brouer-Visser, Jurriaan; Brennan, Laura; Wilson, Sabine; Davydov, Iakov I; Staedler, Nicolas; Duarte, José; Martinez Quetglas, Iris; Nüesch, Eveline; Cañamero, Marta; Chesné, Evelyne; Au-Yeung, George; Hamilton, Erika; Lheureux, Stephanie; Richardson, Debra L; Spanggaard, Iben; Gomes, Bruno; Franjkovic, Izolda; DeMario, Mark; Kornacker, Martin; Lechner, Katharina

A phase 1b dose-escalation/expansion study of BET inhibitor RO6870810 in patients with advanced multiple myeloma

一项针对晚期多发性骨髓瘤患者的BET抑制剂RO6870810的1b期剂量递增/扩展研究

Ramasamy, Karthik; Nooka, Ajay; Quach, Hang; Htut, Myo; Popat, Rakesh; Liedtke, Michaela; Tuchman, Sascha A; Laubach, Jacob; Gasparetto, Cristina; Chanan-Khan, Asher; Hertzberg, Mark; deMario, Mark; Nueesch, Eveline; Chesne, Evelyne; Franjkovic, Izolda; Lechner, Katharina; Kornacker, Martin; Cho, Hearn Jay

Phase 1b study of the BET protein inhibitor RO6870810 with venetoclax and rituximab in patients with diffuse large B-cell lymphoma

在弥漫性大B细胞淋巴瘤患者中,BET蛋白抑制剂RO6870810联合维奈托克和利妥昔单抗的1b期研究

Dickinson, Michael; Briones, Javier; Herrera, Alex F; González-Barca, Eva; Ghosh, Nilanjan; Cordoba, Raul; Rutherford, Sarah C; Bournazou, Eirini; Labriola-Tompkins, Emily; Franjkovic, Izolda; Chesne, Evelyne; Brouwer-Visser, Jurriaan; Lechner, Katharina; Brennan, Barbara; Nüesch, Eveline; DeMario, Mark; Rüttinger, Dominik; Kornacker, Martin; Hutchings, Martin

The McCAVE Trial: Vanucizumab plus mFOLFOX-6 Versus Bevacizumab plus mFOLFOX-6 in Patients with Previously Untreated Metastatic Colorectal Carcinoma (mCRC)

McCAVE试验:Vanucizumab联合mFOLFOX-6方案与Bevacizumab联合mFOLFOX-6方案治疗既往未接受治疗的转移性结直肠癌(mCRC)患者的比较

Bendell, Johanna C; Sauri, Tamara; Gracián, Antonio Cubillo; Alvarez, Rafael; López-López, Carlos; García-Alfonso, Pilar; Hussein, Maen; Miron, Maria-Luisa Limon; Cervantes, Andrés; Montagut, Clara; Vivas, Cristina Santos; Bessudo, Alberto; Plezia, Patricia; Moons, Veerle; Andel, Johannes; Bennouna, Jaafar; van der Westhuizen, Andre; Samuel, Leslie; Rossomanno, Simona; Boetsch, Christophe; Lahr, Angelika; Franjkovic, Izolda; Heil, Florian; Lechner, Katharina; Krieter, Oliver; Hurwitz, Herbert